Rosemary and the Nervous System: What the Research Shows About Memory, Mood, and Stress
Rosemary’s culinary reputation undersells how deeply studied it is as a neuropharmacological herb. A comprehensive 2020 review in the Iranian Journal of Basic Medical Sciences compiled the research on rosemary’s active constituents — chiefly rosmarinic acid, carnosic acid, carnosol, and ursolic acid — and their effects across memory, mood, epilepsy, and neurodegeneration, drawing on both cell/animal research and a growing set of human trials.
The Active Compounds Behind the Effects
Rosemary’s therapeutic reputation rests mainly on four constituents: rosmarinic acid and carnosic acid (the two considered to have the most medicinal significance), plus rosmanol and ursolic acid. These compounds show antimicrobial, anti-inflammatory, antioxidant, anti-apoptotic, antinociceptive (pain-reducing), and neuroprotective properties across the reviewed literature — and rosemary’s overall safety profile is well-established, classified as “generally safe” by the FDA.
Memory, Learning, and Alzheimer’s-Related Research
In middle-aged rats, a rosemary extract standardized to 40% carnosic acid, given for 12 weeks, increased spatial memory performance and boosted activity of the antioxidant enzymes SOD and CAT in the hippocampus — the brain region most central to memory and most vulnerable to oxidative stress. Carnosic acid specifically has been shown to activate the Keap1/Nrf2 antioxidant signaling pathway, the same protective mechanism implicated in several neurodegeneration studies, and in animal models of Alzheimer’s-like pathology, carnosic acid treatment reduced amyloid-β plaque number and improved memory and learning on the Morris water maze test.
Human Evidence, Not Just Animal Models
In a study of 144 healthy volunteers, inhaling rosemary oil produced measurable effects on both mood and objective cognitive performance. Separately, rosemary powder at a normal culinary dose (750 mg) improved memory speed in 28 older adults (mean age 75) — a rare case of a rosemary effect demonstrated at an actual dietary-equivalent dose, not just a concentrated extract.
Mood: Anxiety and Depression
Rosemary extract has shown antidepressant-like effects in multiple animal behavioral tests, working through interactions with noradrenergic, dopaminergic, and serotonergic systems — and chronic administration reduced anhedonic-like behavior (a core depression-like symptom in animal models) similarly to the reference antidepressant fluoxetine. On the anxiety side, inhaled rosemary essential oil reduced stress markers (lowering serum corticosterone) while increasing brain dopamine levels in animal studies, consistent with modulation of the hypothalamic-pituitary-adrenal (HPA) stress axis.
Epilepsy and Neuropathic Pain
Rosemary extract reduced seizure severity and onset in animal models of epilepsy, and reduced neuronal loss and memory impairment following induced seizures — effects the review links to rosemary’s antioxidant and anti-glutamate-toxicity properties. Separately, in a clinical study of 46 diabetic patients, aromatherapy massage with rosemary essential oil significantly reduced neuropathic pain scores and improved quality of life — one of the review’s more directly patient-relevant findings.
The Bottom Line
Across memory, mood, epilepsy, and neuroprotection, rosemary’s effects converge on a consistent set of mechanisms — antioxidant activity via the Keap1/Nrf2 pathway, anti-inflammatory action, and modulation of neurotransmitter systems (dopamine, serotonin, GABA). The evidence spans genuine human trials (aromatherapy, culinary-dose memory studies, neuropathic pain) as well as a much larger body of animal and cell research — the review itself calls for more clinical studies specifically on isolated compounds like carnosic and rosmarinic acid to fully translate these findings into therapeutics.
References
[1] Ghasemzadeh Rahbardar, M.; Hosseinzadeh, H. “Therapeutic effects of rosemary (Rosmarinus officinalis L.) and its active constituents on nervous system disorders.” Iran J. Basic Med. Sci. 2020, 23, 1100–1112. https://doi.org/10.22038/ijbms.2020.45269.10541 (open access)
